Investigating the Effect of Vortioxetine in Adult ADHD Patients

NCT02327013 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: vortioxetine 10 mg tablet
DRUG: vortioxetine 20 mg tablet
OTHER: Placebo tablet

Sponsor

H. Lundbeck A/S